Cargando…
Multi-modal imaging of high-risk ductal carcinoma in situ of the breast using C2Am: a targeted cell death imaging agent
BACKGROUND: Ductal carcinoma in situ (DCIS) is a non-invasive form of early breast cancer, with a poorly understood natural history of invasive transformation. Necrosis is a well-recognized adverse prognostic feature of DCIS, and non-invasive detection of its presence and spatial extent could provid...
Autores principales: | Szucs, Zoltan, Joseph, James, Larkin, Tim J., Xie, Bangwen, Bohndiek, Sarah E., Brindle, Kevin M., Neves, André A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7891030/ https://www.ncbi.nlm.nih.gov/pubmed/33596961 http://dx.doi.org/10.1186/s13058-021-01404-z |
Ejemplares similares
-
Correction to: Multi-modal imaging of high-risk ductal carcinoma in situ of the breast using C2Am: a targeted cell death imaging agent
por: Szucs, Zoltan, et al.
Publicado: (2021) -
(18)F-C2Am: a targeted imaging agent for detecting tumor cell death in vivo using positron emission tomography
por: Bulat, Flaviu, et al.
Publicado: (2020) -
Preclinical PET Imaging of Tumor Cell Death following Therapy Using Gallium-68-Labeled C2Am
por: Bulat, Flaviu, et al.
Publicado: (2023) -
Imaging of Noncalcified Ductal Carcinoma In Situ
por: Bragg, Ashley, et al.
Publicado: (2021) -
A versatile clearing agent for multi-modal brain imaging
por: Costantini, Irene, et al.
Publicado: (2015)